Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksSTAR
resources
STAR

Strides Pharma Science Ltd.

NSE: STAR
BSE: 532531
Sector: Healthcare
Industry: Pharmaceuticals
1,075.30-20.2 (-1.84%)
14 Oct, 12:00 AM

Annual Reports and Financial Documents

Strides Pharma Science Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Strides Pharma Science Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026
  2. Closure of Trading Window24 Sept 2026
    Closure of Trading Window
    Closure of Trading Window for the quarter ended September 30, 2026
  3. General23 Sept 2026
    Strides'' Sustainability Report For FY26
    Strides'' Sustainability Report for FY26
  4. General11 Sept 2026
    Completion Of USFDA Inspection At The Company''s Formulations Facility At Alathur
    Completion of USFDA Inspection at the Company''s Formulation Facility at Alathur
  5. Press Release / Media Release19 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Strides receives USFDA Establishment Inspection Report (EIR) for flagship facility in Bengaluru
  6. AGM18 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Voting results along with Scrutinizers report for 35th AGM.
  7. AGM14 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceedings of 35th Annual General Meeting of the Company
  8. Analyst / Investor Meet3 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Transcript of Earnings Call pertaining to Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
  9. Newspaper Publication1 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper advertisement - Unaudited Financial Results for the quarter ended June 30, 2026
  10. Analyst / Investor Meet31 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording of Earnings Call dated July 31, 2026, pertaining to unaudited financial results for Q1 FY27
  11. Press Release / Media Release31 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Strides Delivers Steady Performance with Q1FY27; Revenue at Rs. 12,654m, Grew 13% YoY; Ex-US Markets Grew 17% YoY
  12. Analyst / Investor Meet24 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Earnings Call to discuss the Unaudited Financial Results of the Company for the quarter ended June 30, 2026
  13. Board Meeting24 Jul 2026
    Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026, Amongst Other Matters.
    Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve the unaudited financial ....
  14. Business Responsibility and Sustainability Reporting (BRSR)21 Jul 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Business Responsibility and Sustainability Report for FY 2026
  15. AGM21 Jul 2026
    Notice Of 35Th Annual General Meeting
    35th Annual General Meeting is scheduled to be held on Friday, August 14, 2026 at 12:15 hrs IST
  16. Reg. 34 (1) Annual Report21 Jul 2026
    Reg. 34 (1) Annual Report.
    Annual Report for FY 2025-26
  17. AGM21 Jul 2026
    Notice Of 35Th Annual General Meeting
    35th Annual General Meeting is scheduled on Friday, August 14, 2026 at 12:15 HRS IST.
  18. Record Date20 Jul 2026
    Company Has Fixed The Record Date For Final Dividend For FY26 As Friday, July 31, 2026
    Company has fixed the Record Date for Final Dividend for FY26 as Friday, July 31, 2026
  19. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
  20. Restructuring3 Jul 2026
    Announcement under Regulation 30 (LODR)-Restructuring
    Update on Completion of Transaction relating to Pivot Path.

Frequently Asked Questions

Where can I download the annual report of Strides Pharma Science Ltd.?
Annual reports of Strides Pharma Science Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Strides Pharma Science Ltd.?
Quarterly earnings results and presentations of Strides Pharma Science Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Strides Pharma Science Ltd. publish earnings call transcripts?
Earnings call transcripts of Strides Pharma Science Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Strides Pharma Science Ltd.?
Investor presentations and annual day presentations of Strides Pharma Science Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Strides Pharma Science Ltd.?
Corporate announcements and regulatory filings of Strides Pharma Science Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Strides Pharma Science Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Strides Pharma Science Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Strides Pharma Science Ltd.?
The ISIN (International Securities Identification Number) of Strides Pharma Science Ltd. is INE939A01011. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Strides Pharma Science Ltd. listed?
Strides Pharma Science Ltd. is listed on NSE and BSE. The NSE symbol is STAR and the BSE code is -.
Where can I find the shareholding pattern of Strides Pharma Science Ltd.?
The quarterly shareholding pattern of Strides Pharma Science Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Strides Pharma Science Ltd. on Sharpely?
Share price data for Strides Pharma Science Ltd. is updated as of 14 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.